The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Expression and function of efflux drug transporters in the intestine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,385
A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants
Juliano, R. L., & Ling, V. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90160-7 · Cited by 3,296
Ertl, P., Rohde, B., & Selzer, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000942e · Cited by 3,084
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H. P., Brockmöller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3473 · Cited by 2,365
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
A family of drug transporters: the multidrug resistance-associated proteins
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1295 · Cited by 1,751
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Cordon-Cardo, C., O'Brien, J. P., Boccia, J., Casals, D., Bertino, J. R., & Melamed, M. R. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.9.1974900 · Cited by 1,062
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)
Austin Doyle, L., & Ross, D. D. (2003) · Oncogene · doi:10.1038/sj.onc.1206938 · Cited by 1,051
Role of P-Glycoprotein in Pharmacokinetics: Clinical Implications
Lin, J. H., & Yamazaki, M. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342010-00003 · Cited by 998
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 929
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 918
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance
Marzolini, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.09.012 · Cited by 895
Expression cloning of a mammalian proton-coupled oligopeptide transporter
Fei, Y.-J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F. H., Romero, M. F., Singh, S. K., Boron, W. F., & Hediger, M. A. (1994) · Nature · doi:10.1038/368563a0 · Cited by 891
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882
Nuclear Receptor Response Elements Mediate Induction of Intestinal MDR1 by Rifampin
Geick, A., Eichelbaum, M., & Burk, O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010173200 · Cited by 848
The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux
Synold, T. W., Dussault, I., & Forman, B. M. (2001) · Nature Medicine · doi:10.1038/87912 · Cited by 840
Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines
Riordan, J. R., Deuchars, K., Kartner, N., Alon, N., Trent, J., & Ling, V. (1985) · Nature · doi:10.1038/316817a0 · Cited by 826
Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plösch, T., Kuipers, F., Elferink, R. P. J. O., Rosing, H., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202607599 · Cited by 822
Allen, J. D., van Loevezijn, A., Rademaker-Lakhai, J. M., van der Valk, M., van Tellingen, O., Reid, G., Schellens, J. H. M., Koomen, G., & Schinkel, A. H. (2002) · PubMed · Cited by 814
Isolation and expression of a complementary DNA that confers multidrug resistance
Gros, P., Neriah, Y. B., Croop, J. M., & Housman, D. E. (1986) · Nature · doi:10.1038/323728a0 · Cited by 797
Pharmacokinetic Interactions with Rifampicin: Clinical Relevance
Niemi, M., Backman, J. T., Fromm, M. F., Neuvonen, P. J., & Kivist??, K. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342090-00003 · Cited by 764
Reduced permeability in CHO cells as a mechanism of resistance to colchicine
Ling, V., & Thompson, L. H. (1974) · Journal of Cellular Physiology · doi:10.1002/jcp.1040830114 · Cited by 686
Büchler, M., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & Keppler, D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 638
Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan
Jonker, J. W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.20.1651 · Cited by 638
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9804011 · Cited by 627
Human Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene Amplification
Shen, D.-W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., & Gottesman, M. M. (1986) · Science · doi:10.1126/science.3457471 · Cited by 603
Hoffmeyer, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050585397 · Cited by 599
Importance of P-glycoprotein at blood–tissue barriers
Fromm, M. F. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.002 · Cited by 592
St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4
Dürr, D. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.112240 · Cited by 584
Chan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582
Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., & Elferink, R. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 552
Clark, D. E. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980402t · Cited by 519
König, J., Rost, D., Cui, Y., & Keppler, D. (1999) · Hepatology · doi:10.1002/hep.510290404 · Cited by 504
Schuetz, E. G., Beck, W. T., & Schuetz, J. D. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08713-9 · Cited by 494
Impact of Drug Transporter Studies on Drug Discovery and Development
Mizuno, N., Niwa, T., Yotsumoto, Y., & Sugiyama, Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.1 · Cited by 490
Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line.
Maliepaard, M., van Gastelen, M. A., de Jong, L. A., Pluim, D., van Waardenburg, R. C., Ruevekamp, M. C., Floot, B. G., & Schellens, J. H. M. (1999) · PubMed · Cited by 487
Kruijtzer, C. M. F., Beijnen, J. H., Rosing, H., ten Bokkel Huinink, W. W., Schot, M., Jewell, R. C., Paul, E. M., & Schellens, J. H. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.116 · Cited by 464
Haufroid, V., Mourad, M., Van Kerckhove, V., Wawrzyniak, J., De Meyer, M., Eddour, D. C., Malaise, J., Lison, D., Squifflet, J.-P., & Wallemacq, P. (2004) · Pharmacogenetics · doi:10.1097/00008571-200403000-00002 · Cited by 447
Taipalensuu, J., Törnblom, H., Lindberg, G., Einarsson, C., Sjöqvist, F., Melhus, H., Garberg, P., Sjöström, B., Lundgren, B., & Artursson, P. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29314-9 · Cited by 444
Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4
Bhardwaj, R. K., Glaeser, H., Becquemont, L., Klotz, U., Gupta, S. K., & Fromm, M. F. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034728 · Cited by 444
The orphan nuclear receptor HNF4α determines PXR- and CAR-mediated xenobiotic induction of CYP3A4
Tirona, R. G., Lee, W., Leake, B. F., Lan, L.-B., Cline, C. B., Lamba, V., Parviz, F., Duncan, S. A., Inoue, Y., Gonzalez, F. J., et al. (2003) · Nature Medicine · doi:10.1038/nm815 · Cited by 440
Pharmacokinetic-Pharmacodynamic Drug Interactions with HMG-CoA Reductase Inhibitors
Williams, D., & Feely, J. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241050-00003 · Cited by 423
Wacher, V. J., Silverman, J. A., Zhang, Y., & Benet, L. Z. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980082d · Cited by 423
Localisation of breast cancer resistance protein in microvessel endothelium of human brain
Cooray, H. C., Blackmore, C. G., Maskell, L., & Barrand, M. A. (2002) · NeuroReport · doi:10.1097/00001756-200211150-00014 · Cited by 419
St John's wort (Hypericum perforatum): drug interactions and clinical outcomes
Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B., & Arlett, P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01683.x · Cited by 380
Nies, A. T., Jedlitschky, G., König, J., Herold-Mende, C., Steiner, H. H., Schmitt, H.-P., & Keppler, D. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 379
Herbal Modulation of P‐Glycoprotein
Zhou, S., Lim, L. Y., & Chowbay, B. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-120028427 · Cited by 375
Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure
Wessel, M. D., Jurs, P. C., Tolan, J. W., & Muskal, S. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci980029a · Cited by 365
Riordan, J. R., & Ling, V. W. T. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86370-6 · Cited by 362
Kool, M., van der Linden, M., de Haas, M., Baas, F., & Borst, P. (1999) · PubMed · Cited by 361
Flavonoids Are Inhibitors of Breast Cancer Resistance Protein (ABCG2)-Mediated Transport
Zhang, S., Yang, X., & Morris, M. E. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.5.1208 · Cited by 359
Characterization of Human Small Intestinal Cytochromes P-450
Zhang, Q.-Y., Dunbar, D., Ostrowska, A., Zeisloft, S., Yang, J., & Kaminsky, L. S. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15229-4 · Cited by 343
Cisternino, S., Mercier, C., Bourasset, F., Roux, F., & Scherrmann, J.-M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2033 · Cited by 329
Expression of members of the multidrug resistance protein family in human term placenta
St-Pierre, M. V., Serrano, M. A., Macias, R. I. R., Dubs, U., Hoechli, M., Lauper, U., Meier, P. J., & Marin, J. J. G. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1495 · Cited by 325
Kabanov, A. V., Batrakova, E. V., & Miller, D. W. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00176-x · Cited by 325
Interindividual Variability and Tissue-Specificity in the Expression of Cytochrome P450 3A mRNA
Koch, I., Weil, R., Wolbold, R., Brockmöller, J., Hustert, E., Burk, O., Nuessler, A., Neuhaus, P., Eichelbaum, M., Zanger, U., et al. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.10.1108 · Cited by 314
Shapiro, A. B., Fox, K., Lam, P., & Ling, V. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00098.x · Cited by 304
Schaub, T. P., Kartenbeck, J., König, J., Vogel, O., Witzgall, R., Kriz, W., & Keppler, D. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v881213 · Cited by 294
Batrakova, E. V., Li, S., Vinogradov, S. V., Alakhov, V. Y., Miller, D. W., & Kabanov, A. V. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29254-5 · Cited by 292
Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery
Benet, L. Z., Izumi, T., Zhang, Y., Silverman, J. A., & Wacher, V. J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00034-6 · Cited by 292
Burger, H., Foekens, J. A., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Wiemer, E. A. C., Stoter, G., & Nooter, K. (2003) · PubMed · Cited by 292
Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR
Ito, K., Suzuki, H., Hirohashi, T., Kume, K., Shimizu, T., & Sugiyama, Y. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.1.g16 · Cited by 290
Amplification and Expression of Genes Associated with Multidrug Resistance in Mammalian Cells
Scotto, K. W., Biedler, J. L., & Melera, P. W. (1986) · Science · doi:10.1126/science.2421411 · Cited by 287
Westphal, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109797 · Cited by 285
ABCG2 – a transporter for all seasons
Sarkadi, B., Özvegy-Laczka, C., Német, K., & Váradi, A. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.123 · Cited by 282
Mayer, U., Wagenaar, E., Beijnen, J. H., Smit, J. W., Meijer, D. K. F., van Asperen, J., Borst, P., & Schinkel, A. H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15775.x · Cited by 282
The Effect of Rifampin Treatment on Intestinal Expression of Human MRP Transporters
Fromm, M. F., Kauffmann, H.-M., Fritz, P., Burk, O., Kroemer, H. K., Warzok, R. W., Eichelbaum, M., Siegmund, W., & Schrenk, D. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64794-3 · Cited by 277
P-Glycoprotein Increases from Proximal to Distal Regions of Human Small Intestine
Mouly, S., & Paine, M. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1026183200740 · Cited by 276
Diestra, J. E., Scheffer, G. L., Català, I., Maliepaard, M., Schellens, J. H. M., Scheper, R. J., Germà‐Lluch, J. R., & Izquierdo, M. A. (2002) · The Journal of Pathology · doi:10.1002/path.1203 · Cited by 275
van Herwaarden, A. E., Jonker, J. W., Wagenaar, E., Brinkhuis, R. F., Schellens, J. H. M., Beijnen, J. H., & Schinkel, A. H. (2003) · PubMed · Cited by 269
FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA
Kobayashi, D., Ieiri, I., Hirota, T., Takane, H., Maegawa, S., Kigawa, J., Suzuki, H., Nanba, E., Oshimura, M., Terakawa, N., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001628 · Cited by 268
Hauptman, P. J., & Kelly, R. A. (1999) · Circulation · doi:10.1161/01.cir.99.9.1265 · Cited by 268
Hirohashi, T., Suzuki, H., Ito, K., Ogawa, K., Kume, K., Shimizu, T., & Sugiyama, Y. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13278-6 · Cited by 266
Van der Bliek, A. M., Van der Velde-Koerts, T., Ling, V, & Borst, P. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1671 · Cited by 258
Wada, M. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.203 · Cited by 257
SCHAUB, T. P., KARTENBECK, J., KÖNIG, J., SPRING, H., DÖRSAM, J., STAEHLER, G., STÖRKEL, S., THON, W. F., & KEPPLER, D. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061159 · Cited by 256
von Richter, O., Burk, O., Fromm, M. F., Thon, K. P., Eichelbaum, M., & Kivistö, K. T. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.008 · Cited by 255
Increased vinblastine binding to membrane vesicles from multidrug-resistant KB cells.
Cornwell, M. M., Gottesman, M. M., & Pastan, I. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57491-9 · Cited by 253
Tsuchiya, N., Satoh, S., Tada, H., Li, Z., Ohyama, C., Sato, K., Suzuki, T., Habuchi, T., & Kato, T. (2004) · Transplantation · doi:10.1097/01.tp.0000137789.58694.b4 · Cited by 250
Breast Cancer Resistance Protein Directly Confers SN-38 Resistance of Lung Cancer Cells
Kawabata, S., Oka, M., Shiozawa, K., Tsukamoto, K., Nakatomi, K., Soda, H., Fukuda, M., Ikegami, Y., Sugahara, K., Yamada, Y., et al. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4267 · Cited by 242
Yoh, K., Ishii, G., Yokose, T., Minegishi, Y., Tsuta, K., Goto, K., Nishiwaki, Y., Kodama, T., Suga, M., & Ochiai, A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0937-3 · Cited by 242
Expression and Localization of Multidrug Resistant Protein mrp2 in Rat Small Intestine
Mottino, A. D., Hoffman, T., Jennes, L., & Vore, M. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39291-2 · Cited by 239
Rifampin and Rifabutin Drug Interactions: An Update
Finch, C. K., Chrisman, C. R., Baciewicz, A. M., & Self, T. H. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.9.985 · Cited by 233
Toh, S., Wada, M., Uchiumi, T., Inokuchi, A., Makino, Y., Horie, Y., Adachi, Y., Sakisaka, S., & Kuwano, M. (1999) · The American Journal of Human Genetics · doi:10.1086/302292 · Cited by 231
Interaction of the breast cancer resistance protein with plant polyphenols
Cooray, H. C., Janvilisri, T., van Veen, H. W., Hladky, S. B., & Barrand, M. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.040 · Cited by 226
Wang, R. B., Kuo, C. L., Lien, L. L., & Lien, E. J. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2003.00487.x · Cited by 225
Fricker, G., Drewe, J., Huwyler, J., Gutmann, H., & Beglinger, C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15612.x · Cited by 223
Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease
Adibi, S. A. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00056.2003 · Cited by 221
Suzuki, H., & Sugiyama, Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00075-3 · Cited by 211
Homolya, L., Váradi, A., & Sarkadi, B. (2003) · BioFactors · doi:10.1002/biof.5520170111 · Cited by 208
Ho, G.-T., Moodie, F. M., & Satsangi, J. (2003) · Gut · doi:10.1136/gut.52.5.759 · Cited by 204
Effect of clarithromycin on renal excretion of digoxin: Interaction with P-glycoprotein*
Wakasugi, H., Yano, I., Ito, T., Hashida, T., Futami, T., Nohara, R., Sasayama, S., & Inui, K.-I. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90030-3 · Cited by 200
Siegmund, W., Ludwig, K., Giessmann, T., Dazert, P., Schroeder, E., Sperker, B., Warzok, R., Kroemer, H. K., & Cascorbi, I. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.127739 · Cited by 199
Gefitinib reverses breast cancer resistance protein–mediated drug resistance
Yanase, K., Tsukahara, S., Asada, S., Ishikawa, E., Imai, Y., & Sugimoto, Y. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1119.3.9 · Cited by 196
Boll, M., Markovich, D., Weber, W. M., Korte, H., Daniel, H., & Murer, H. (1994) · Pflügers Archiv European Journal of Physiology · doi:10.1007/bf02584043 · Cited by 191
Goto, M., Masuda, S., Kiuchi, T., Ogura, Y., Oike, F., Okuda, M., Tanaka, K., & Inui, K.-I. (2004) · Pharmacogenetics · doi:10.1097/01.fpc.0000114747.08559.49 · Cited by 189
Trezise, A. E., Romano, P. R., Gill, D. R., Hyde, S. C., Sepúlveda, F. V., Buchwald, M., & Higgins, C. F. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05528.x · Cited by 186
Yumoto, R., Murakami, T., Nakamoto, Y., Hasegawa, R., Nagai, J., & Takano, M. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38117-0 · Cited by 184
Self-citationTerada, T., & Inui, K.-I. (2004) · Current Drug Metabolism · doi:10.2174/1389200043489153 · Cited by 177
Westphal, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.107579 · Cited by 177
Efflux transporters of the human placenta
Young, A. M., Allen, C. E., & Audus, K. L. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00174-6 · Cited by 171
Hong, J., Lambert, J. D., Lee, S.-H., Sinko, P. J., & Yang, C. S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.09.007 · Cited by 169
GIESSMANN, T., MAY, K., MODESS, C., WEGNER, D., HECKER, U., ZSCHIESCHE, M., DAZERT, P., GRUBE, M., SCHROEDER, E., & WARZOK, R. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.011 · Cited by 167
Rost, D., Mahner, S., Sugiyama, Y., & Stremmel, W. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00318.2001 · Cited by 166
Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T., & Yamamoto, A. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20017 · Cited by 165
Bart, J., Hollema, H., Groen, H. J. M., de Vries, E. G. E., Hendrikse, N. H., Sleijfer, D. T., Wegman, T. D., Vaalburg, W., & van der Graaf, W. T. A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.05.010 · Cited by 164
Effect of bioflavonoids on vincristine transport across blood–brain barrier
Mitsunaga, Y., Takanaga, H., Matsuo, H., Naito, M., Tsuruo, T., Ohtani, H., & Sawada, Y. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00180-1 · Cited by 161
P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans
Drescher, S., Glaeser, H., Mürdter, T., Hitzl, M., Eichelbaum, M., & Fromm, M. F. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.27 · Cited by 158
Induction of Drug Metabolising Enzymes: Pharmacokinetic and Toxicological Consequences in Humans
Fuhr, U. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038060-00003 · Cited by 154
Honda, Y., Ushigome, F., Koyabu, N., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706008 · Cited by 151
Zheng, H., Zeevi, A., Schuetz, E. G., Lamba, J. K., McCurry, K. R., Griffith, B. P., Webber, S., Ristich, J., Dauber, J. H., Iacono, A. T., et al. (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003262108 · Cited by 149
Mottino, A. D., Cao, J., Veggi, L. M., Crocenzi, F. A., Roma, M. G., & Vore, M. E. (2002) · Hepatology · doi:10.1053/jhep.2002.33327 · Cited by 149
Rengelshausen, J., Göggelmann, C., Burhenne, J., Riedel, K., Ludwig, J., Weiß, J., Mikus, G., Walter‐Sack, I., & Haefeli, W. E. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01824.x · Cited by 148
P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans
Schwarz, U. I., Gramatté, T., Krappweis, J., et al. (2000) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38161 · Cited by 146
Gotoh, Y., Suzuki, H., Kinoshita, S., Hirohashi, T., Kato, Y., & Sugiyama, Y. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35309-1 · Cited by 144
Okano, T., Inui, K., Maegawa, H., Takano, M., & Hori, R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66992-3 · Cited by 141
Self-citationTakano, M., Hasegawa, R., Fukuda, T., Yumoto, R., Nagai, J., & Murakami, T. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00607-4 · Cited by 141
Self-citationLee, Y. J., Kusuhara, H., Jonker, J. W., Schinkel, A. H., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.073320 · Cited by 140
Prime-Chapman, H. M., Fearn, R. A., Cooper, A. E., Moore, V., & Hirst, B. H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068775 · Cited by 140
The effects of fruit juices on drug disposition: a new model for drug interactions
Dresser, G. K., & Bailey, D. G. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.33.s2.2.x · Cited by 139
Transport of Peptidomimetic Drugs by the Intestinal Di/tri‐peptide Transporter, PepT1
Brodin, B., Nielsen, C. U., Steffansen, B., & Frøkjær, S. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900601.x · Cited by 133
Gramatté, T., Oertel, R., Terhaag, B., & Kirch, W. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90182-4 · Cited by 131
Gießmann, T., Modeß, C., Hecker, U., Zschiesche, M., Dazert, P., Kunert‐Keil, C., Warzok, R., Engel, G., Weitschies, W., Cascorbi, I., et al. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.004 · Cited by 130
Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in rats.
Chu, X., Kato, Y., & Sugiyama, Y. (1997) · PubMed · Cited by 129
Liedert, B., Materna, V., Schadendorf, D., Thomale, J., & Lage, H. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12313.x · Cited by 129
Dey, S., Patel, J., Anand, B. S., Jain-Vakkalagadda, B., Kaliki, P., Pal, D., Ganapathy, V., & Mitra, A. K. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.02-1142 · Cited by 128
P-glycoprotein and surfactants: Effect on intestinal talinolol absorption
Bogman, K., Aschmann, Y. Z., DEGEN, L., Gérard Hopfgartner, D., Gutmann, H., Alsenz, J., & Drewe, J. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.001 · Cited by 126
Dexamethasone modulation of multidrug transporters in normal tissues
Demeule, M., Jodoin, J., Beaulieu, É., Brossard, M., & Béliveau, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01663-9 · Cited by 125
Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol
Spahn-Langguth, H., & Langguth, P. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00191-3 · Cited by 125
Molecular determinants of treatment response in human germ cell tumors.
Mayer, F., Stoop, H., Scheffer, G. L., Scheper, R. J., Oosterhuis, J. W., Looijenga, L. H. J., & Bokemeyer, C. (2003) · PubMed · Cited by 116
Regulation of UDP glucuronosyltransferases in the gastrointestinal tract
Gregory, P. A. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.01.008 · Cited by 115
Multiple mechanisms confer drug resistance to mitoxantrone in the human 8226 myeloma cell line.
Hazlehurst, L., Foley, N. E., Gleason-Guzman, M. C., Hacker, M. P., Cress, A. E., Greenberger, L., de Jong, M. C., & Dalton, W. S. (1999) · PubMed · Cited by 115
Paulusma, C. C., & Elferink, R. P. J. O. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050127 · Cited by 113
Allen, J. D., Dort, S. C. V., Buitelaar, M., van Tellingen, O., & Schinkel, A. H. (2003) · PubMed · Cited by 113
Shoda, J., Kano, M., Oda, K., Kamiya, J., Nimura, Y., Suzuki, H., Sugiyama, Y., Miyazaki, H., Todoroki, T., Stengelin, S., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05339.x · Cited by 112
Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver
Shoda, J., Miura, T., Utsunomiya, H., Oda, K., Yamamoto, M., Kano, M., Ikegami, T., Tanaka, N., Akita, H., Ito, K., et al. (2004) · Hepatology · doi:10.1002/hep.20003 · Cited by 109
Clinically Significant Interactions with Drugs Used in the Treatment of Tuberculosis
Ww, Y. (2002) · Drug Safety · doi:10.2165/00002018-200225020-00005 · Cited by 107
Chiou, W. L., Chung, S. M., Wu, T. C., & Ma, C. (2001) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp39093 · Cited by 106
Effects of Grapefruit Juice and Orange Juice on the Intestinal Efflux of P-Glycoprotein Substrates
Tian, R., Koyabu, N., Takanaga, H., Matsuo, H., Ohtani, H., & Sawada, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1016100715125 · Cited by 103
Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil*
Gramatté, T., & Oertel, R. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70031-7 · Cited by 98
Expression and functional analyses of breast cancer resistance protein in lung cancer.
Kawabata, S., Oka, M., Soda, H., Shiozawa, K., Nakatomi, K., Tsurutani, J., Nakamura, Y., Doi, S., Kitazaki, T., Sugahara, K., et al. (2003) · PubMed · Cited by 95
Sugiyama, Y., Kato, Y., & Chu, X. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051078 · Cited by 95
Transporter-mediated Drug Interactions
Tsuji, A. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.253 · Cited by 94
Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40
Tayrouz, Y., Ding, R., Burhenne, J., Riedel, K., Weiß, J., Hoppe‐Tichy, T., Haefeli, W. E., & Mikus, G. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00059-6 · Cited by 94
Regulation of Drug and Bile Salt Transporters in Liver and Intestine
Kullak-Ublick, G. A., & Becker, M.-B. (2003) · Drug Metabolism Reviews · doi:10.1081/dmr-120026398 · Cited by 93
Landowski, C. P., Sun, D., Foster, D. R., Menon, S. S., Barnett, J. L., Welage, L. S., Ramachandran, C., & Amidon, G. L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051011 · Cited by 93
Hu, M., Subramanian, P. K., Mosberg, H. I., & Amidon, G. L. (1989) · Pharmaceutical Research · doi:10.1023/a:1015855820488 · Cited by 91
Chu, X., Kato, Y., Ueda, K., Suzuki, H., Niinuma, K., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., et al. (1998) · PubMed · Cited by 90
Özvegy‐Laczka, C., Köblös, G., Sarkadi, B., & Váradi, A. (2004) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2004.11.005 · Cited by 90
Adachi, Y., Suzuki, H., Schinkel, A. H., & Sugiyama, Y. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.007393 · Cited by 90
Prediction of Membrane Permeability to Peptides from Calculated Dynamic Molecular Surface Properties
Stenberg, P., Luthman, K., & Artursson, P. (1999) · Pharmaceutical Research · doi:10.1023/a:1018816122458 · Cited by 85
Rapid Assessment of P-Glycoprotein Inhibition and Induction in Vitro
Perloff, M. D., Störmer, E., Moltke, L. L., & Greenblatt, D. J. (2003) · Pharmaceutical Research · doi:10.1023/a:1025092829696 · Cited by 85
Inui, K., Okano, T., Maegawa, H., Kato, M., Takano, M., & Hori, R. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20008-8 · Cited by 84
Self-citationInduction of P-glycoprotein expression by HIV protease inhibitors in cell culture
Perloff, M. D., Moltke, L. L., Fahey, J. M., et al. (2000) · AIDS · doi:10.1097/00002030-200006160-00034 · Cited by 83
Ryu, S., Kawabe, T., Nada, S., & Yamaguchi, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005149200 · Cited by 82
Yeast suppressors of UAA and UAG nonsense codons work efficiently in vitro via tRNA
Gesteland, R. F., Wolfner, M. F., Grisafi, P. L., Fink, G. R., Botstein, D., & Roth, J. R. (1976) · Cell · doi:10.1016/0092-8674(76)90167-7 · Cited by 81
Dietrich, C. G., Geier, A., Salein, N., Lammert, F., Roeb, E., Elferink, R. P. J. O., Matern, S., & Gartung, C. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.046 · Cited by 76
Variable expression of CYP and Pgp genes in the human small intestine
Lindell, M., Karlsson, M. O., Lennernäs, H., Påhlman, L., & Lang, M. A. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01154.x · Cited by 74
Horikawa, M., Kato, Y., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1020358910490 · Cited by 73
Hu, M., & Borchardt, R. T. (1990) · Pharmaceutical Research · doi:10.1023/a:1015906409585 · Cited by 72
Kauffmann, H.-M., KEPPLER, D. O. R., Gant, T. W., & Schrenk, D. (1998) · Archives of Toxicology · doi:10.1007/s002040050571 · Cited by 71
Koike, K., Conseil, G., Leslie, E. M., Deeley, R. G., & Cole, S. P. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311435200 · Cited by 69
Preserved organic anion transport in mutant TR- rats with a hepatobiliary secretion defect
Jansen, P. L. M., van Klinken, J. W., van Gelder, M., Ottenhoff, R., & Elferink, R. P. J. O. (1993) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1993.265.3.g445 · Cited by 68
Materna, V., Pleger, J., Hoffmann, U., & Lage, H. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.03.035 · Cited by 64
Disposition and bioavailability of the β1‐adrenoceptor antagonist talinolol in man
Trausch, B., Oertel, R., Richter, K., & Gramatté, T. (1995) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.2510160505 · Cited by 64
Jäger, W. R., Winter, O., Halper, B., Maier‐Salamon, A., Sartori, M., Gajdzik, L., Hamilton, G., Theyer, G., Graf, J., & Thalhammer, T. (1997) · Hepatology · doi:10.1002/hep.510260613 · Cited by 64
Biliary Excretion of 17β-Estradiol 17β-d-Glucuronide Is Predominantly Mediated by cMOAT/MRP2
Morikawa, A., Goto, Y., Suzuki, H., Hirohashi, T., & Sugiyama, Y. (2000) · Pharmaceutical Research · doi:10.1023/a:1026412915168 · Cited by 63
Ito, K., Suzuki, H., & Sugiyama, Y. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1077 · Cited by 63
Bonin, S., Pascolo, L., Crocè, L. S., Stanta, G., & Tiribelli, C. (2002) · Molecular Medicine · doi:10.1007/bf03402158 · Cited by 59
Steinbach, D., Lengemann, J., Voigt, A., et al. (2003) · PubMed · Cited by 59
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital
INNOCENTI, F., UNDEVIA, S., RAMIREZ, J., MANI, S., SCHILSKY, R., VOGELZANG, N., PRADO, M., & RATAIN, M. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.07.016 · Cited by 57
Yumoto, R., Murakami, T., Sanemasa, M., Nasu, R., Nagai, J., & Takano, M. (2001) · PubMed · Cited by 56
Self-citationDemeule, M., Brossard, M., Turcotte, S., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.141 · Cited by 52
Stephens, R. H., O’Neill, C. A., Bennett, J., Humphrey, M., Henry, B., Rowland, M., & Warhurst, G. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704668 · Cited by 51
Romiti, N., Tramonti, G., & Chieli, E. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9461 · Cited by 49
Ji, B., Ito, K., Suzuki, H., Sugiyama, Y., & Horie, T. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00906-1 · Cited by 48
Shibayama, Y., Ikeda, R., Motoya, T., & Yamada, K. (2004) · Food and Chemical Toxicology · doi:10.1016/j.fct.2004.02.012 · Cited by 48
Zhang, D., Gu, H.-M., Situ, D., Haimeur, A., Cole, S. P. C., & Deeley, R. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308403200 · Cited by 47
Chen, C., Scott, D. O., Hanson, E., Franco, J., Berryman, E. R., Volberg, M. L., & Liu, X. (2003) · Pharmaceutical Research · doi:10.1023/a:1022238506509 · Cited by 43
Han, H.-K., Rhie, J. K., Oh, D.-M., Saito, G., Hsu, C.-P., Stewart, B. H., & Amidon, G. L. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980132e · Cited by 42
Takara, K., Takagi, K., Tsujimoto, M., Ohnishi, N., & Yokoyama, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00922-7 · Cited by 40
P‐glycoprotein Interactions of Nefazodone and Trazodone in Cell Culture
Störmer, E., Moltke, L. L., Perloff, M. D., & Greenblatt, D. J. (2001) · The Journal of Clinical Pharmacology · doi:10.1177/00912700122010609 · Cited by 37
Zhang, D., Nunoya, K., Vasa, M. Z., Gu, H.-M., Theis, A., Cole, S. P. C., & Deeley, R. G. (2004) · Biochemistry · doi:10.1021/bi0495230 · Cited by 35
Tissue selective drug delivery utilizing carrier-mediated transport systems
Tsuji, A. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00043-7 · Cited by 35
Zhang, D., Gu, H.-M., Vasa, M. Z., Muredda, M., Cole, S. P. C., & Deeley, R. G. (2003) · Biochemistry · doi:10.1021/bi034462b · Cited by 35
Konno, T., Ebihara, T., Hisaeda, K., Uchiumi, T., Nakamura, T., Shirakusa, T., Kuwano, M., & Wada, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302868200 · Cited by 31
Tanaka, K., Hirai, M., Tanigawara, Y., Ueda, K., Takano, M., Hori, R., & Inui, K.-I. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00810-6 · Cited by 27
Self-citationNaba, H., Kuwayama, C., Kakinuma, C., Ohnishi, S., & Ogihara, T. (2004) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.19.339 · Cited by 24
Expression of ATP-binding cassette transporter in human salivary ducts
Uematsu, T., Yamaoka, M., Doto, R., et al. (2003) · Archives of Oral Biology · doi:10.1016/s0003-9969(02)00159-0 · Cited by 21
Kuppens, I. E. L. M., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Colorectal Cancer · doi:10.3816/ccc.2004.n.017 · Cited by 18
Cited by
Advances in Oral Drug Delivery
Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 876
Deli, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.016 · Cited by 385
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Somogyi, A. A., Barratt, D. T., & Coller, J. K. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100095 · Cited by 324
Toxicology and risk assessment of coumarin: Focus on human data
Abraham, K., Wöhrlin, F., Lindtner, O., Heinemeyer, G., & Lampen, A. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900281 · Cited by 292
Metadata
- Authors
- Takano, M., Yumoto, R., & Murakami, T.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 109
- Issue
- 1-2
- Pages
- 137-161
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1997813700
- Cited by
- 356
- References
- 198
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.